Skip to main
STE
STE logo

STERIS (STE) Stock Forecast & Price Target

STERIS (STE) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 0%
Buy 83%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Steris reported total revenue of $1,480.5 million for fiscal fourth quarter 2025, reflecting a 5.0% year-over-year increase on an organic basis. The company's EBIT margin improved by 110 basis points compared to the previous year, indicating enhanced operational efficiency. Additionally, Steris achieved a quarterly earnings per share (EPS) of $2.74, representing a 14% increase from the prior-year period, supported by lower interest expenses following the divestment of its dental segment.

Bears say

Steris has reported a significant decline in its capital equipment segment, with a decrease of approximately 16% year-over-year, while service revenues fell by 21%, indicating a weak demand in critical areas of its business. The company’s capital backlog has also shown a concerning trend, dropping by $1 million to $84 million compared to the prior period, raising questions about its future sales potential. Furthermore, achieving sustained earnings and dividend growth appears challenging, as the company relies on mid-single digit revenue growth, which may be difficult given the current market dynamics and potential delays in capital equipment sales recovery.

STERIS (STE) has been analyzed by 6 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 83% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of STERIS and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About STERIS (STE) Forecast

Analysts have given STERIS (STE) a Buy based on their latest research and market trends.

According to 6 analysts, STERIS (STE) has a Buy consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $273.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $273.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

STERIS (STE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.